Skip to main content

Instant redemption funds, UPI payments, KYC and more on the MobiKwik App!

Latest NAV & returns of TATA ASSET MANAGEMENT LTD.

Tata India Pharma & Healthcare Fund Regular Payout of Inc Dist cum Cap Wdrl

Add To Compare

previously known as Tata India Pharma & Healthcare Reg DP until

NAV on October 01, 2026
Category Equity:
Sector - Healthcare
Investment StyleBox
Total Assets ₹1,565 cr
Turnover Ratio 65.05%
Expense Ratio 2.32%
Exit Load 0.25%if redeemed within
30 Days
0.00%if redeemed after 30 Days
Returns
  • 1M: Negative return: -4.40%
  • 1Y: Positive return: 6.25%
  • 3M: Negative return: -0.50%
  • 3Y: Positive return: 16.49%
  • 6M: Positive return: 14.25%
  • 5Y: Positive return: 12.31%
Min Investment ₹5,000
ADDITIONAL INFO
Fund Manager Rajat Srivastava (Since about 2 years)
ISIN INF277K017A7
Fund Family Tata
P/E Ratio 40.58
P/B Ratio 6.28
Launch Date December 28, 2015
Benchmark Nifty Pharma TR INR

Asset Allocation

  • Equity: 99.5%
  • Debt: 0.5%
EQUITY DISTRIBUTION
RISK MEASURES (3 yrs)
vs Nifty Pharma TR INR

Alpha -3.03
Beta 0.99
R-Squared 93.20
Info Ratio -0.86
Tracking Err 4.35
Sortino 1.041
Sharpe 0.646
Std Dev 16.707
Risk -
SECTOR WEIGHTINGS (%)
Financial 0.51%
Industrial 0.0%
Technology 0.0%
Basic Materials 7.07%
Consumer Cyclical 0.0%
Utilities Services 0.0%
Healthcare Services 91.33%
Energy Services 0.00%
Communication Services 0.00%
Consumer Defensive 1.09%
Real Estate 0.00%
INVESTMENT OBJECTIVE

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

View Factsheet

-

Best Sector Healthcare Funds

Name Latest NAV Returns 1y   Fund Assets Expense Ratio Risk
₹ 51.144 20.26% ₹ 3,555 cr 0.61% -
₹ 584.618 20.19% ₹ 5,796 cr 1.04% -
₹ 378.650 16.65% ₹ 1,444 cr 1.26% -


Other plans of Tata India Pharma & Healthcare


Other Equity funds by Tata